| Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664) |
|---|
| 08/30/2005 | US6936597 A conjugate of blocked polymer with a biologically active compound containing reactive hydroxy or amino groups |
| 08/25/2005 | WO2005077945A2 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| 08/25/2005 | WO2005077887A1 Novel method of synthesis and novel crystalline form of agomelatine and pharmaceutical compositions containing said form |
| 08/25/2005 | US20050187402 T-butoxycarbonylaminoethylamine for the synthesis of PNA monomer units, amino acid derivatives, intermediates thereof, and processes for productions of them |
| 08/25/2005 | US20050187297 New compounds, methods for their preparation and use thereof |
| 08/25/2005 | US20050187246 Cell proliferation inhibitors |
| 08/25/2005 | US20050187167 Polyene polyketides, processes for their production and their use as a pharmaceutical |
| 08/25/2005 | US20050186176 Compounds and compositions for delivering active agents |
| 08/25/2005 | CA2827964A1 Glyoxalated polyacrylamide compositions |
| 08/25/2005 | CA2555291A1 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| 08/24/2005 | EP1565443A2 Acetyl 2-hydroxy-1,3 diaminoalkanes |
| 08/24/2005 | EP1565433A2 Novel ligands that are antagonists of rar receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 08/24/2005 | EP1565422A1 Vitamin d receptor modulators |
| 08/24/2005 | EP1299349B1 Compounds to treat alzheimer's disease |
| 08/24/2005 | CN1659220A Conversion products of mixtures of long-chained fatty acids and aliphatic diamines, and the use thereof |
| 08/24/2005 | CN1659136A Novel sodium channel blockers |
| 08/24/2005 | CN1659135A Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia |
| 08/24/2005 | CN1659130A Induction of apoptosis in cancer cells |
| 08/24/2005 | CN1216039C Fluorinated dihydric alcohol |
| 08/23/2005 | US6933410 Process for preparing 5,6-diethyl-2,3-dihydro-1H-inden-2-amine |
| 08/23/2005 | US6933404 Methods of making intermediates from polyhydroxyalkanoates |
| 08/23/2005 | US6933385 A pentanoic amide derivatives as chemical intermediates for antitumor agents |
| 08/23/2005 | US6933319 Resorcinol derivatives |
| 08/23/2005 | CA2266884C Inhibition of 26s and 20s proteasome by indanones |
| 08/23/2005 | CA2153235C Compounds having selectivity for retinoid x receptors |
| 08/18/2005 | WO2005075410A1 New compounds, methods for their preparation and use thereof |
| 08/18/2005 | WO2005074912A2 Antiparasitic composition containing an organic amine salt of closantel |
| 08/18/2005 | US20050182276 Process for the synthesis and crystalline form of agomelatine |
| 08/18/2005 | US20050182235 Methods of making intermediates from polyhydroxyalkanoates |
| 08/18/2005 | US20050182134 Anticancer agents; phenyl amide or phenyl ester derivatives of flurbiprofen for example; prodrug of a quinone methide or iminoquinone methide |
| 08/18/2005 | US20050182040 Benzamide derivatives |
| 08/18/2005 | CA2553039A1 Antiparasitic composition |
| 08/18/2005 | CA2552942A1 New compounds, methods for their preparation and use thereof |
| 08/17/2005 | EP1564202A1 Novel process for synthesizing and a novel crystal form of agomelatin as well as pharmaceutical preparations containing these |
| 08/17/2005 | EP1562595A1 Diaryl ethers as opioid receptor antagonists |
| 08/17/2005 | EP1562594A2 Methylene-bridged selective androgen receptor modulators and methods of use thereof |
| 08/17/2005 | EP1140841B1 3-phenyl-2,6-dioxopiperidin-3-yl propionamide derivatives and method for preparing same |
| 08/17/2005 | CN1656065A Ligand as the RAR receptor inhibitor |
| 08/17/2005 | CN1656057A N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors |
| 08/16/2005 | US6930203 gelling agents or thickeners have the form of an N,N'-disubstituted aldaramide or N,N'-disubstituted pentaramide |
| 08/16/2005 | US6930185 Anorectic agents; obesity; such as 4'-chloro-N-(6-((N,N-dimethylamino)methyl)-2-naphthyl)(1,1'-biphenyl)-4 -carbox-amide |
| 08/16/2005 | US6930106 Inhibitors of HCV NS5B polymerase |
| 08/16/2005 | CA2342974C Methods and compositions for inhibition of angiogenesis |
| 08/16/2005 | CA2166059C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 08/11/2005 | WO2005073216A2 Hcv ns-3 serine protease inhibitors |
| 08/11/2005 | WO2005073195A2 Hcv ns-3 serine protease inhibitors |
| 08/11/2005 | WO2005056510A3 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |
| 08/11/2005 | WO2004110983A8 New benzamides as pparϒ modulators |
| 08/11/2005 | US20050176994 Simultaneously or continuously reacting a sulfuric ester alkylating agent, an aromatic hydrocarbon preferably containing an electron withdrawing group and an electron donating group, and a maleic anhydride derivative. |
| 08/11/2005 | US20050176779 dioxodihydropyridine derivatives and certain methacrylic acid and furan derivative precursors thereof; use as tumor growth inhibitors and anti-cancer agents, antibiotics and/or antiviral agents |
| 08/11/2005 | US20050176766 2,3-Oxidosqualene-lanosterol cyclase inhibitors |
| 08/11/2005 | US20050175682 Polyethyleneglycol-modified lipid compounds and uses thereof |
| 08/11/2005 | CA2552317A1 Hcv ns-3 serine protease inhibitors |
| 08/10/2005 | EP1444195B1 Process for the preparation of alpha-hydroxycarboxylic acid amides |
| 08/10/2005 | EP1157002B1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy |
| 08/10/2005 | CN1653030A Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative |
| 08/10/2005 | CN1652759A Small molecule entry inhibitors |
| 08/10/2005 | CN1651392A 2-and 2, 5-substituted phenylketoenols |
| 08/10/2005 | CN1213998C Processes and intermediates useful to make antifolates |
| 08/09/2005 | US6927303 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 08/09/2005 | US6927228 Biphenyl compounds usefuf in treatment of human and veterinary medicines such as dermatology, cardivovascular diseases, immune diseases or diseases associated with lipid metabolisms, or in cosmetic formulation |
| 08/09/2005 | US6926810 Mixing a feed stream and at least one azeotroping agent; decomposing the ammonium salt, the amide, or the alkylamine-organic acid complex to produce organic acid producing a first vapor stream; separating |
| 08/09/2005 | CA2327029C Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline |
| 08/09/2005 | CA2093084C Ferrocenyl diphosphines as ligands for homogeneous catalysts |
| 08/04/2005 | WO2005070910A2 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme |
| 08/04/2005 | WO2005070871A2 Amino alcohol derivatives and their activity as renin inhibitors |
| 08/04/2005 | WO2005070856A1 Octahydronaphthalene derivative and medicine |
| 08/04/2005 | WO2005037206A3 Anti-cancer compounds and methods of use thereof |
| 08/04/2005 | US20050171204 2S)-3-(4-{2-[(Cyclohexylmethyl)(heptyl)amino]-2-oxoethoxy}phenyl)-2-ethoxypropanoic acid; treating lipid disorders (dyslipidemias), insulin resistance |
| 08/04/2005 | US20050171148 Aryl and heteroaryl compounds, compositions, methods of use |
| 08/04/2005 | US20050171068 Novel 4-dedimethylaminotetracycline derivatives |
| 08/04/2005 | US20050171065 NAALADas, N-Acetylated-Alpha-Linked-Acidic-Dipeptidase inhibitors; 5-phosphonomethyl-1,3-benzenedicarboxylic Acid; glutamate abnormalities, anticancer, antidiabetic agent, angiogenesis inhibitor, neuropathy, pain, compulsive disorders, prostate diseases, glaucoma |
| 08/04/2005 | US20050170427 For activated slides for preparing microarrays of nucleic acids; solid phase synthesis |
| 08/04/2005 | CA2553840A1 Amino alcohol derivatives and their activity as renin inhibitors |
| 08/03/2005 | EP1559422A1 Receptor function controlling agent |
| 08/03/2005 | EP1558567A1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds |
| 08/03/2005 | EP1558565A2 Halogenated selective androgen receptor modulators and methods of use thereof |
| 08/03/2005 | CN1650237A Charge controllers |
| 08/03/2005 | CN1213038C Benzophenones as inhibitors of reverse transcriptase |
| 08/03/2005 | CN1213020C Phenylalaninol derivatives |
| 08/02/2005 | US6924392 Ortho, meta-substituted bisaryl compounds, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them |
| 08/02/2005 | US6924388 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 08/02/2005 | US6924314 Compounds for the treatment of metabolic disorders |
| 08/02/2005 | US6924310 Sulfur compounds such as N-[3,5-dichloro-4-(3-cyclopropylsulfamoyl-4-hydroxy-phenoxy)-phenyl]-malonamic acid, used as anoroexigenic, antiarrhythmia, hypotensive or antidiabetic agents; alopecia |
| 08/02/2005 | US6924307 Metalloproteinase inhibitor; antiarthritic agents, osteoporosis; cardiovascular disorders; antitumor agents; autoimmune diseases |
| 08/02/2005 | US6924304 Compounds such as N-((dimethylamino)acetyl)-1-methyl-N-(3, 4,5-trimethoxyphenyl)-1H-indole-5-sulfonamide for therapy of cancer |
| 08/02/2005 | CA2362339C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 08/02/2005 | CA2362337C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 08/02/2005 | CA2170020C Retroviral protease inhibiting compounds |
| 07/28/2005 | WO2005068416A1 Amide compound and method for controlling plant disease using same |
| 07/28/2005 | WO2005068414A1 Catalytic hydrogenation of nitriles to produce capsaicinoid derivatives and amine compounds, and methods for purifiying and obtaining the polymorphs thereof |
| 07/28/2005 | WO2005068412A1 Ketone compounds and compositions for cholesterol management and related uses |
| 07/28/2005 | WO2005068403A2 Method for selective reduction of aromatic compounds |
| 07/28/2005 | US20050165114 Antiinflammatory agent, immunosuppressant, anticancer agents, antiarthritic agents; AP-1 activation inhibitor, NF-kappa B activation inhibitor |
| 07/28/2005 | US20050165108 reacting D-phenylalanine methylester HCl with trans-4-isopropylcyclohexane carboxylic acid in presence of propane phosphonic acid anhydride or LiOH Al2O3 in a halogenated hydrocarbon solvent such as dichloromethane or dichloroethane; type 2 diabetes mellitus |
| 07/28/2005 | US20050165066 Antiproliferative agents |
| 07/28/2005 | US20050165058 Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla |
| 07/28/2005 | US20050164953 Beta-secretase inhibitors |
| 07/28/2005 | DE10360745A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
| 07/28/2005 | CA2552438A1 Method for selective reduction of aromatic compounds |